Position in AMGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$5,159,847
+$22,134 QoQ
Shares Held
14,249
-2.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#824
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Crestwood Advisors Group, LLC holds $223,873,417 across 13 Drug Manufacturers - General names. AMGN ranks #6 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
268,723 | $68,247,580 | |
| 2 | LLY |
ELI LILLY & Co
|
44,320 | $53,158,741 | |
| 3 | AZN |
Astrazeneca PLC
|
224,312 | $42,534,041 | |
| 4 | ABBV |
AbbVie Inc.
|
122,966 | $30,943,164 | |
| 5 | MRK |
Merck & Co., Inc.
|
114,219 | $14,677,141 | |
| 6 | AMGN |
Amgen Inc
This page
|
14,249 | $5,159,847 | |
| 7 | PFE |
Pfizer Inc
|
137,811 | $3,318,488 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
20,797 | $2,627,492 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,159,847 | 14,249 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $5,137,713 | 14,602 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $4,618,016 | 14,109 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $3,795,025 | 13,448 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,974,144 | 10,652 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,356,328 | 10,773 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,732,810 | 10,485 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $3,388,038 | 10,515 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $3,268,227 | 10,460 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,600,959 | 9,148 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,595,636 | 9,012 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,400,026 | 8,930 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,704,447 | 7,677 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,561,705 | 6,460 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,172,687 | 4,465 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $991,985 | 4,401 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $1,035,728 | 4,257 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $980,821 | 4,056 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $887,506 | 3,945 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $813,173 | 3,824 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $967,931 | 3,971 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,021,365 | 4,105 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $1,082,003 | 4,706 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $1,180,319 | 4,644 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $1,108,306 | 4,699 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $943,099 | 4,652 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||